Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors

NCT06416007 is registered in ClinicalTrials.gov with University of Cincinnati as lead sponsor.

NCT NCT06416007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06416007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors
Lead sponsor
University of Cincinnati
Phase
Phase 2
Overall status
Recruiting
Start date
August 2, 2024
Completion date
June 1, 2027
Enrollment
37 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, locally advanced, locally advanced carcinoma, locally advanced solid tumor, metastatic cancer